Home › Trials › NCT07148258
Clinical trial Recruiting at 1 site Interventional

Improving early intervention for toddlers with communication delays in Georgia

Official title: Evaluating Georgia Part C Implementation Outcomes

Run by Emory University · NCT07148258 · Data updated 2026-11-12

This project will try two ways of training Georgia Early Intervention providers in Project ImPACT to see which approach helps families of children under 3 with autism-related communication delays get better support.

Quick facts

Study typeInterventional
SexAll
Enrollment20 (estimated)
SponsorEmory University
Academic / other
Locations1 site (Atlanta, Georgia)
StatusRecruiting
StartedSeptember 3, 2025
Main results expectedSeptember 2028
Study endsSeptember 2028
Registry record updatedMay 19, 2026
Trial IDNCT07148258 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are English-speaking caregivers of children under 36 months who are enrolled in Georgia's Early Intervention program and are seen by a provider participating in Project ImPACT training.

Probably not a fit

Children not enrolled in Georgia's EI system, older than 36 months, served by providers not using Project ImPACT, or families who do not speak English are unlikely to benefit from this project.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The project trains 150 Georgia Early Intervention (EI) providers in one of two Project ImPACT training models to compare how well each approach is implemented within routine EI services. Researchers will measure implementation process and quality, factors that influence delivery, and preliminary child social-communication and parent empowerment outcomes. Caregivers whose providers deliver Project ImPACT can opt to complete surveys before and after the program plus an exit interview, or a single confidential post-program survey, with all research activities conducted at the Marcus Autism Center. Because the training is embedded in standard EI professional development, the focus is on real-world implementation and adaptation rather than testing a new clinical therapy.

Why it matters

Potential benefit: If successful, the project could help EI providers deliver Project ImPACT more effectively, improving young children's social communication and parents' confidence in supporting them.

How similar studies have gone: Project ImPACT is an evidence-based, parent-mediated intervention with prior studies showing benefits for child social communication, but its large-scale implementation within state EI systems is less well tested.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria for Providers:

* Currently employed or contracted by Georgia's EI system
* Maintain an active therapy caseload
* Fluent in English.

Inclusion Criteria for Caregivers:

* Have a child under 36 months currently enrolled in services through Georgia's Early Intervention system
* Are being seen by a provider participating in Project ImPACT training and research
* Fluent in English.

Exclusion Criteria for both Providers and Caregivers:

* Not meeting the eligibility criteria.

Where it's running

  • Marcus Autism Center
    Atlanta, Georgia, United States     Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Communication Disorder, Childhood 2Autism 558Emory University 2068
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.